Internal Diseases – Part 1 (Rheumatology, Pulmonology, Phthisiatrics, Cardiology, Haematology) · MU Plovdiv

15. Multiple Myeloma

Inside: 2 sections · 2 labelled pictures · 15 flashcards · 7 min

Topic 64 of 68 in the MU Plovdiv syllabus for Internal Diseases – Part 1 (Rheumatology, Pulmonology, Phthisiatrics, Cardiology, Haematology) (Medicine, Year 4). The free AceMed note covers it in 2 sections, about 1,016 words (7 min of reading), with 15 flashcards.

In this note

  1. Essay 15- Multiple myeloma
  2. Myeloma multiplex

Essay 15- Multiple myeloma

Definition

  • Multiple myeloma is a neoplastic disease characterized by plasma cell accumulation in the bone marrow, the presence of monoclonal protein in the serum and/or urine and tissue damage!

Etiology

  • Exact etiology unknown!
  • Translocations and alterations in promotor genes (chromosome 14) are commonly found and likely play a role
  • Other oncogenes may participate in plasma cell proliferation (NRAS, KRAS, BRAF)

Pathophysiology

  • MM is essentially a stage in the spectrum of monoclonal gammopathy!
  • Thought to arise from a pre-malignant, asymptomatic phase of clonal plasma cell growth called monoclonal gammopathy of undetermined significance (MGUS)
  • Genetic alterations may cause an increased expression of promoter genes or resistance to apoptosis, both resulting in higher plasma cell proliferation and population
  • Under the "second hit" hypothesis, progression could also be a consequence of additional cytogenetic lesions gained by the original plasma cell clone

Durie and Salmon staging

  • Durie and Salmon staging
  • Class I- small tumour mass
  • Class 2- intermediate tumour mass
  • Class 3- increase in tumour mass
  • A- creatinine is less than 2mg/dL
  • B- creatinine is more than 2mg/dL

Symptoms

  • Acronym for tissue damage:
  • C- hypercalcemia
  • R- renal impairment
  • A- anemia
  • B- bone disease
  • Bone pain- resulting from vertebral collapse and pathological fractures
  • Features of anemia (lethargy, weakness)
  • Recurrent infections
  • Features of renal failure and/or hypercalcemia
  • Abnormal tendency to bleed- platelet function may be disrupted
  • Amyloidosis- seen in 5%
  • Hyperviscosity syndrome- seen in 2%

Diagnosis

  • Symptomatic myeloma is diagnosed if there is:
  • Monoclonal protein in serum and/or urine
  • Increased clonal plasma cells in the bone marrow
  • Related organ or tissue impairment
  • Lab findings:
  • CBC- normochromic, normocytic or macrocytic anemia
  • Presence of paraproteinemia- IgG in 60% of cases and IgA in 20%
  • Elevated serum Ig free light chains
  • Immunoparesis- reduced normal serum IgG, IgA, IgM
  • High ESR
  • Hypercalcemia
  • Bone marrow- increased plasma cells
  • Greater than or equal to 10%!
  • Radiography- osteolytic areas without evidence of surrounding osteoblastic reaction
  • Raised serum creatinine in 20%

Treatment

Supportive

  • Renal impairment- hydration with 3L of water a day
  • Dialysis if indicated
  • Bone disease and hypercalcemia- bisphosphonates (zoledronic acid) and rehydration using isotonic saline, diuretic and corticosteroid
  • Compression paraplegia- surgical decompression laminectomy or irradiation
  • Anemia- transfusion or EPN
  • Bleeding- plasmapheresis
  • Infections- oral antibiotics (broad) or antifungal agents)

Specific

Intensive combination chemo

  • 4-6 courses of chemo
  • Followed by autologous SCT (high procedure-related mortality)
  • Drugs used combine 2 or 3 which are bortezomib, dexamethasone, thalidomide, lenalidomide, cyclophosphamide!
  • VTD – bortezomib (velcade), thalidomide and dexamethasone

Continue reading free

The whole note, all 2 sections, is free with an AceMed account, with its 15 flashcards. Premium adds flashcard recall, highlights and Ask AI.